Region: Latin America & Caribbean

Biologics and biosimilars in Brazil – the strategic questions

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

This chapter highlights the strategic questions surrounding patent prosecution, patent litigation and the regulation of biologics and biosimilars on the Brazilian market.

06 May 2020

A guide for second medical use claims in Brazil

Featured in IAM Life Sciences: Key issues for senior life sciences executives 2020

One of the most common questions regarding patent protection in Brazil refers to whether there is a possibility of protecting second medical use of known chemical compounds. The answer is simple: yes, it is possible to protect second medical use in Brazil.

06 May 2020

How to patent second medical uses in Brazil

Innovators must overcome demanding inventive step and novelty requirements to protect repurposed drugs in Latin America’s largest market

04 May 2020

Private equity investor buys majority stake in IP pioneer Ocean Tomo

New capital will help Chicago-based business scale-up as it looks to develop new marketplace, says firm's head Jim Malackowski; possible expansion of international arm into India and Brazil also being considered

24 April 2020

Johnson & Johnson, Gilead and Roche are the world’s antiviral patent leaders

A covid-19 vaccine could be produced by anyone, but only a few major players had been actively strengthening and building their portfolios before the pandemic struck

17 April 2020

World leaders hatch further plans for accessibility of covid-19 IP rights

WHO to establish voluntary patent pool, while Greek Prime Minister calls for EU to buy rights to vaccines and tests

09 April 2020

From the IAM archive – the decision makers

A selection of some of the exclusive interviews we have run with the indviduals running the world's most important patent offices

08 April 2020

The key covid-19 compulsory licensing developments so far

Several countries have introduced new laws – or have faced calls – to strengthen their ability to bypass patents

07 April 2020

New dates announced for IPBC Global and IPBC Europe

Free Talking Heads webinar series on key issues in IP management, the market and value creation also launched

06 April 2020

People in rich countries have no right to free IP

It’s only because the developed world feels threatened by the coronavirus that initiatives such as the Open COVID pledge have gained such support

04 April 2020

Unlock unlimited access to all IAM content